Association of Ferritin and HbA1c with Disease Severity in COVID-19 Patients

Abstract

Abstract

Space The World Health Organization (WHO) declared a new coronavirus infection brought on by the SARS-CoV-2 virus to be a pandemic on March 11, 2020, making it the eleventh pandemic in the previous century. To assess the clinical symptoms and laboratory data (Ferritin & HbA1c biomarkers' level), 150 patients diagnosed with COVID-19 pneumonia and 50 healthy controls were included in the study. The Real-Time RT-PCR Assay was used to diagnose every COVID-19 patient. According to data analysis, COVID-19 patients had significantly higher levels of D-dimer, Ferritin, and HbA1c at the time of admission (P < 0.001), and there was a strong correlation between D-dimer levels and HbA1c (P ≤ 0.001). In conclusion, COVID-19 individuals who have persistently elevated ferritin and HbA1c levels are more likely to have a poor prognosis. To reduce their bad prognosis due to COVID-19, patients with ferritin and HbA1c readings over cutoff criteria should be properly controlled.